Searched for
AYURVEDIC TABLET
Influx Healthtech IPO subscribed over 41 times on Day 3; GMP signals strong listingInflux Healthtech's IPO witnessed an overwhelming response, being oversubscribed 41.07 times, driven by strong retail and NII participation...- Influx Healthtech IPO subscribed 1.7 times on Day 1; GMP points to strong listing popInflux Healthtech IPO: In the unlisted market, Influx Healthtech’s grey market premium (GMP) was Rs 42 at 11:54 AM on Wednesday, suggesting...
- Influx Healthtech IPO opens today: Check key details before subscribingInflux Healthtech, a Mumbai-based CDMO, launches its IPO today, aiming to raise ₹55.63 crore through a fresh issue and offer-for-sale. The ...
- Approval given to use Coronil as supporting measure in Covid management: MoS HealthMinister of State for Health Bharati Pravin Pawar, in a written reply, said the Interdisciplinary Technical Review Committee (ITRC) setup b...
- Coronil flies off shelves despite IMA red flag amid second wave“We ran out of Coronil tablets/kit over the last few weeks due to high demand,” said Kapil Pangasa, owner of a general store on Delhi’s Pri...
- Antiviral drug 'Clevira' repurposed for treating mild to moderate COVID-19 patientsA clinical trial was conducted on 100 people in May-June last year and the results were "promising", the company said. The selected 100 par...
- Patanjali condemns IMA for seeking explanation from Dr Harsh Vardhan over CoronilThe Indian Medical Association (IMA) on Monday demanded an explanation from Union Health Minister Dr Harsh Vardhan for promoting Patanjali'...
- Ayurveda drugs can be effective in mild to moderate cases of COVID-19: AIIACiting the case of a 30-year-old male health worker infected with coronavirus, the report said his infection was managed with Samshamana th...
- Dabur expands baby care product portfolio, launches 8 new Ayurveda-based productsCommenting on the development Dabur India Marketing Head-Healthcare OTC Ajay Singh Parihar said, "With the growing demand of baby care prod...
- Didn't promote COVID-19 cure, just shared trial results: PatanjaliThe claim triggered a row with the Union AYUSH ministry telling the herbal products firm not to sell the drug till it has examined the issu...
- Ayush ministry to examine Patanjali's claims on Covid-19 treatmentThe ministry has also reached out to the Uttarakhand government to provide copies of license and approval details granted for the manufactu...
- Coronavirus outbreak: Ayush pushes ‘traditional cure’, med council backs modern drugsThe advisory suggests intake of anti-malarial Ayurvedic drug, AYUSH 64, developed by the ministry, use of sesame oil in the nose, and tulsi...
- Search for immunity powers up sales of Ayurveda productsEven though the Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa Rigpa and Homoeopathy (Ayush) has issued an advisory recommen...
- Dengue can now be cured sooner, thanks to this Ayurvedic drug created by Indian scientistsThe medicine is likely to be available in the market by next year.
- Chhattisgarh plans to start large scale production of herbal drugsAs per the plan, Ayurvedic drug manufacturers would be invited to set up herbal drug production units in the state, based on PPP mode.
- Himalaya Drugs may go for omni-channel retailingThe Bengaluru-based company plans to make available a tablet in all its 150 outlets across the country for consumers to browse and order an...
- Ayushakti gets export nod from German Ministry of HealthExport of over 60 products, following the regulatory nod, has facilitated in treatment of Ayushakti's large patients base from Germany.
- Ajanta Pharma jumps on talks with Dabur India to sell brandAjanta Pharma rose more than 6 pc after Dabur India was in talks to buy '30-Plus' multi-vitamin supplement brand from Ajanta Pharma.
- Dabur India eyes Ajanta Pharma's 30-Plus brandThe deal is expected this week and will be under 50 crore, one of the officials said, requesting anonymity.
- Dabur appeals against 'Pachmola' saleFMCG major Dabur, which owns the 'Hajmola' brand of digestive tablets, is unable to digest another pill by almost the same name - 'Pachmola...
Load More
